Skip to main content

Genitourinary

Protocols

Bladder


GUAJPG

Adjuvant therapy for urothelial carcinoma using CISplatin and gemcitabine


GUAVPG

Palliative therapy for urothelial carcinoma using CISplatin and gemcitabine


GUBCG

Therapy for high risk superficial transitional cell bladder cancer using BCG


GUBCGIFN

Palliative Therapy for BCG-Refractory Superficial High-Grade Transitional Cell Carcinoma Bladder with BCG and Interferon


GUBGEM

Intravesical Therapy for Non-Muscle Invasive Bladder Cancer using Gemcitabine


GUBMITO

Intravesical Therapy for Non-Muscle Invasive Bladder Cancer using Mitomycin

GUBPWRT

Treatment of Locally Advanced Bladder Cancer with Weekly CISplatin and Concurrent Radiation


GUMVAC

Therapy for transitional cell cancers of the urothelium using Methotrexate, vinBLAstine, DOXOrubicin and CISplatin


GUNAJPG

Neo-Adjuvant Therapy for Urothelial Carcinoma Using CISplatin and Gemcitabine

Prostate

UGUPABI

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Abiraterone and predniSONE


UGUPCABA

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Cabazitaxel and predniSONE


GUPDOC

Palliative Therapy for Metastatic Hormone Refractory Prostate Cancer Using DOCEtaxel and predniSONE


GUPDOCADT

First-Line Treatment of Castration Sensitive, Metastatic Prostate Cancer Using DOCEtaxel and Androgen Deprivation Therapy 


UGUPENZ

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Enzalutamide


GUPLHRH

Therapy for Prostate Cancer Using LHRH agonist (Goserelin, Leuprolide or Buserelin)


GUPLHRHA

Therapy for Advanced Prostate Cancer Using LHRH antagonist Degarelix


GUPMX

Palliative therapy for hormone-refractory prostate cancer using mitoXANTRONE and predniSONE


GUPNSAA

Non-Steroidal Treatment of Prostate Cancer


UGUPRAD

Therapy for Metastatic Castration Resistant Prostate Cancer Using Radium-223


Testicular

GUBEP

Curative Therapy for germ cell cancer using Bleomycin, Etoposide and CISplatin


GUEP

Therapy for nonseminoma germ cell cancer using Etoposide-CISplatin


GUSCARB

Adjuvant therapy for stage I high risk seminoma using CARBOplatin


UGUTAXGEM

Palliative therapy for germ cell cancers using PACLitaxel and gemcitabine


UGUTIP

Therapy for Relapsed Testicular Germ Cell cancer using PACLitaxel, lfosfamide and CISplatin (TIP)


GUVEIP

Consolidation/ Salvage Treatment for Germ Cell Cancer Using VinBLAstine, CISplatin, Ifosfamide and Mesna


GUVIP2

Consolidation and Salvage Therapy for Nonseminoma Using Etoposide, CISplatin, Ifosfamide, Mesna

Renal/Kidney

UGUAVIPNI

Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Ipilimumab and Nivolumab


UGUAVNIV

Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Nivolumab


UGUAVNIV4

Treatment of Metastatic or Advanced Renal Cell Carcinoma Using 4-Weekly Nivolumab


UGUAXIT

Therapy for Metastatic Renal Cell Carcinoma Using Axitinib


GUEVER

Therapy for Advanced Renal Cancer Using Everolimus


UGUPAZO

Palliative Therapy for Renal Cell Carcinoma Using Pazopanib


UGUSORAF

Palliative Therapy for Renal Cell Carcinoma Using SORAfenib


UGUSUNI

Palliative Therapy for Renal Cell Carcinoma Using SUNItinib


GUTEM

Therapy for Advanced Renal Cancer Using Temsirolimus

Miscellaneous

GUAVD

Palliative Therapy for Advanced Adrenal Cortical Cancer Using DOXOrubicin


GUEDPM

Treatment of Metastatic Adrenocortical Cancer with Etoposide, DOXOrubicin, CISplatin and Mitotane


GUFUPRT

Combined Modality Therapy for Squamous Cell Cancer of the Genitourinary System Using Fluorouracil and CISplatin with Radiation


GUMITO

Treatment of Adrenal Cortical Cancer with Mitotane


GUSCPE

Palliative Therapy of Extensive Stage Genitourinary Small Cell Tumours with a Platinum and Etoposide


GUSCPERT

Therapy of Genitourinary Small Cell Tumors with a Platin and Etoposide with Radiation


Terms of use

The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

Use of these documents is at your own risk and is subject to BC Cancer's Terms of Use.
Tab Heading
Tab Heading
SOURCE: Genitourinary ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2019 Provincial Health Services Authority